# WR 279,396 for the Treatment of Cutaneous Leishmaniasis

> **NCT01988909** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 18 (actual)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **DRUG:** WR 279,396

## Key facts

- **NCT ID:** NCT01988909
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01988909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01988909, "WR 279,396 for the Treatment of Cutaneous Leishmaniasis". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT01988909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*